Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 4, 2010, Pages 948-954

  Hoenicka, Janet ^a,b   Garrido, Elena ^b   Ponce, Guillermo ^a,b   Rodríguez Jiménez, Roberto ^a,b   Martínez, Isabel ^a,b   Rubio, Gabriel ^a,b   Jiménez Arriero, Miguel Ángel ^a,b   Palomo, Tomás ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Catechol O methyltransferase; Dopamine D1 receptor; Genetic epistasis; Schizophrenia; Val158Met polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 1 RECEPTOR; METHIONINE; VALINE;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; FEMALE; GENES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D1; RISK FACTORS; SCHIZOPHRENIA;

EID: 77952689944     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31065     Document Type: Article

References (39)

1. Abi-Dargham A, Moore H. 2003. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9(5): 404-416.
2. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R., et al. 2002. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22(9):3708-3719. (Pubitemid 37465776)
3. Batel P, Houchi H, Daoust M, Ramoz N, Naassila M, Gorwood P. 2008. A haplotype of the DRD1 gene is associated with alcohol dependence. Alcohol Clin Exp Res 32(4):567-572. (Pubitemid 351430427)
4. Beninger RJ, Miller R. 1998. Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev 22(2):335-345. (Pubitemid 28194390)
5. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, Clasen LS, Sharp WS, Inoff-Germain G, Wavrant-De Vrieze F, et al. 2005. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet Part B Neuropsychiatr Genet 134B(1):67-72.
6. Campion D, d'Amato T, Bastard C, Laurent C, Guedj F, Jay M, Dollfus S, Thibaut F, Petit M, Gorwood P, et al. 1994. Genetic study of dopamine D1, D2, and D4 receptors in schizophrenia. Psychiatry Res 51(3): 215-230.
7. Cichon S, Nothen MM, Stober G, Schroers R, Albus M, Maier W, Rietschel M, Korner J, Weigelt B, Franzek E, et al. 1996. Systematic screening for mutations in the 5′-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder. Am J Med Genet 67(4):424-428.
8. Del Zompo M, De Luca V, Severino G, Ni X, Mulas S, Congiu D, Piccardi MP, Kennedy JL. 2007. Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia. Am J Med Genet Part B Neuropsychiatr Genet 144B(2): 237-241.
9. Dempster EL, Mill J, Craig IW, Collier DA. 2006. The quantification of COMT mRNA in post mortem cerebellum tissue: Diagnosis, genotype, methylation and expression. BMC Med Genet 7:10.
10. Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, Czerski PM, Leszczynska -Rodziewicz A, Kapelski P, Kaczmarkiewicz-Fass M, Hauser J. 2006. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology 53(1):46-50. (Pubitemid 43254177)
11. Dolzan V, Plesnicar BK, Serretti A, Mandelli L, Zalar B, Koprivsek J, Breskvar K. 2007. Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment. Am J Med Genet Part B Neuropsychiatr Genet 144B(6):809-815. (Pubitemid 47417211)
12. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66(2):87-98. (Pubitemid 351482562)
13. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98(12):6917-6922. (Pubitemid 32538317)
14. First MBSR, Gibbon M, Williams JBLB. 1995. Structured clinical interview for DSM-IV axis I disorders patient edition (SCID-IP, Version 2.0). New York: Biometric Research, New York State, Psychiatric Institute.
15. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV. 2004. Targeting the dopamine D1 receptor in schizophrenia: Insights for cognitive dysfunction. Psychopharmacology (Berl) 174(1):3-16. (Pubitemid 38925085)
16. Hettinger JA, Liu X, Schwartz CE, Michaelis RC, Holden JJ. 2008. A DRD1 haplotype is associated with risk for autism spectrum disorders in male-only affected sib-pair families. Am J Med Genet Part B Neuropsychiatr Genet 147B(5):628-636. (Pubitemid 351961666)
17. Hoenicka J, Garrido E, Martínez I, Ponce G, Aragüés M, Rodríguez-Jiménez R, España-Serrano L, Alvira-Botero X, Santos JL, Rubio G, et al. 2010. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am J Med Genet Part B Neuropsychiatr Genet 153B(1):79-85.
18. Hoogendoorn ML, Bakker SC, Schnack HG, Selten JP, Otten HG, Verduijn W, van der Heijden FM, Pearson PL, Kahn RS, Sinke RJ. 2005. No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. Am J Med Genet Part B Neuropsychiatr Genet 134B(1):6-9.
19. Huang W, Li MD. 2009. Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry 65(8):702-705.
20. Huang W, Ma JZ, Payne TJ, Beuten J, Dupont RT, Li MD. 2008. Significant association of DRD1 with nicotine dependence. Hum Genet 123(2): 133-140.
21. Hwang R, Shinkai T, De Luca V, Ni X, Potkin SG, Lieberman JA, Meltzer HY, Kennedy JL. 2007. Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response. J Psychopharmacol 21(7):718-727. (Pubitemid 47439830)
22. Iwata Y, Matsumoto H, Minabe Y, Osada N, Nakamura K, Sekizawa T, Suzuki K, Sekine Y, Takei N, Mori N. 2003. Early-onset schizophrenia and dopamine-related gene polymorphism. Am J Med Genet Part B Neuropsychiatr Genet 116B(1):23-26. (Pubitemid 37063608)
23. Jiang H, Xie T, Ramsden DB, Ho SL. 2003. Human catechol-O- methyltransferase down-regulation by estradiol. Neuropharmacology 45(7): 1011-1018.
24. Kojima H, Ohmori O, Shinkai T, Terao T, Suzuki T, Abe K. 1999. Dopamine D1 receptor gene polymorphism and schizophrenia in Japan. Am J Med Genet 88(2):116-119. (Pubitemid 29156445)
25. Koster A, Lajer M, Lindhardt A, Rosenbaum B. 2008. Gender differences in first episode psychosis. Soc Psychiatry Psychiatr Epidemiol 43(12): 940-946.
26. Lee SH, Mouradian MM. 1999. Up-regulation of D1A dopamine receptor gene transcription by estrogen. Mol Cell Endocrinol 156(1-2):151-157. (Pubitemid 29460754)
27. Lidow MS, Rakic P. 1992. Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cereb Cortex 2(5):401-416.
28. Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, Nussbaum R, Weinberger DR, Berman KF. 2005. Midbrain dopamine and prefrontal function in humans: Interaction and modulation by COMT genotype. Nat Neurosci 8(5):594-596. (Pubitemid 40594200)
29. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsushima E, et al. 1997. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385(6617):634-636.
30. Potkin SG, Basile VS, Jin Y, Masellis M, Badri F, Keator D, Wu JC, Alva G, Carreon DT, Bunney WE Jr., et al. 2003. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol Psychiatry 8(1):109-113.
31. Reich DE, Goldstein DB. 2001. Detecting association in a case-control study while correcting for population stratification. Genet Epidemiol 20(1):4-16.
32. Rinaldi A, Mandillo S, Oliverio A, Mele A. 2007. D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice. Neuropsychopharmacology 32(2):309-319. (Pubitemid 46106938)
33. Rybakowski JK, Borkowska A, Czerski PM, Kapelski P, Dmitrzak-Weglarz M, Hauser J. 2005. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. J Neural Transm 112(11):1575-1582. (Pubitemid 41504271)
34. Slifstein M, Kolachana B, Simpson EH, Tabares P, Cheng B, Duvall M, Frankle WG, Weinberger DR, Laruelle M, Abi-Dargham A. 2008.COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET. Mol Psychiatry 13(8):821-827.
35. Talkowski ME, Kirov G, Bamne M, Georgieva L, Torres G, Mansour H, Chowdari KV, Milanova V, Wood J, McClain L, et al. 2008. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet 17(5):747-758.
36. Tanaka S. 2006. Dopaminergic control of working memory and its relevance to schizophrenia: A circuit dynamics perspective. Neuroscience 139(1):153-171.
37. Tunbridge EM, Harrison PJ, Weinberger DR. 2006. Catechol-o- methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60(2):141-151.
38. Williams GV, Castner SA. 2006. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 139(1):263-276.
39. Xie T, Ho SL, Ramsden D. 1999. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56(1):31-38. (Pubitemid 29309809)